HIV and Retroviral Diseases
A retrovirus can be a type of virus belonging to the Retroviridae family that transmits its genetic outline within ribonucleic acid (RNA). Retroviruses are named after the enzyme reverse transcriptase, which was discovered by American virologists Howard Temin and David Baltimore in 1971. A switch transcriptase can be a protein that switches via RNA to deoxyribonucleic acid (DNA), thereby altering the normal course of cellular translation (DNA to RNA) Since the switch transcriptase operation, the heritable structure from the retrovirus has the potential to enter the DNA genome of the infected cell forever.
In the organic sciences, protein is widely used to combine properties. Human immunodeficiency infection (HIV) could be a retrovirus that causes acquired immunodeficiency disorder (Helps) in humans. Simian immunodeficiency virus (SIV), a retrovirus prevalent in chimpanzees and gorillas, is closely related to HIV.
Related Conference of HIV and Retroviral Diseases
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
HIV and Retroviral Diseases Conference Speakers
Recommended Sessions
- HIV Drug Discovery and Research
- AIDS stigma and discrimination
- Awareness and knowledge on HIV/AIDS, STDs and STIs
- Emerging Technologies towards HIV/AIDS
- HIV & Vaccines
- HIV and Aging
- HIV and AIDS Nursing Care Management
- HIV and bone damage
- HIV and cardiovascular disease
- HIV and Retroviral Diseases
- HIV Diagnosis and Therapy
- HIV in women
- HIV Testing
- HIV/AIDS Nursing and AIDS awareness
- Lived experience of HIV
- Pediatric HIV AIDS
- Side effects of HIV
- Venereal Diseases Prevention and Treatment
- Viral Immunology and Vaccines development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)